BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhou J, Shuang O, Li J, Cai Z, Wu C, Wang W. miR-34a alleviates spinal cord injury via TLR4 signaling by inhibiting HMGB-1. Exp Ther Med 2019;17:1912-8. [PMID: 30783468 DOI: 10.3892/etm.2018.7102] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
Number Citing Articles
1 Wu Z, Li M. High-Mobility Group Box 1 in Spinal Cord Injury and Its Potential Role in Brain Functional Remodeling After Spinal Cord Injury. Cell Mol Neurobiol 2023;43:1005-17. [PMID: 35715656 DOI: 10.1007/s10571-022-01240-5] [Reference Citation Analysis]
2 Wang L, Song Z, Zou H, Chen H, Hu Y, Li X, Liu J. CircRNA3616 knockdown attenuates inflammation and apoptosis in spinal cord injury by inhibiting TLR4/NF-κB activity via sponging miR-137. Mol Cell Biochem 2023;478:329-41. [PMID: 35913538 DOI: 10.1007/s11010-022-04509-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Ding W, Xu W, Lu D, Sheng H, Xu X, Xu B, Zheng A. Inhibition of TERC inhibits neural apoptosis and inflammation in spinal cord injury through Akt activation and p-38 inhibition via the miR-34a-5p/XBP-1 axis. Open Med (Wars) 2023;18:20220619. [PMID: 36742154 DOI: 10.1515/med-2022-0619] [Reference Citation Analysis]
4 Mo Y, Chen K. Review: The role of HMGB1 in spinal cord injury. Front Immunol 2022;13:1094925. [PMID: 36713448 DOI: 10.3389/fimmu.2022.1094925] [Reference Citation Analysis]
5 Deng C, Deng L, Lv J, Sun L. Therapeutic effects and long-term outcomes of HMGB1-targeted therapy in rats and mice with traumatic spinal cord injury: A systematic review and meta-analysis. Front Neurosci 2022;16:968791. [DOI: 10.3389/fnins.2022.968791] [Reference Citation Analysis]
6 Luo Q, Ma H, Guo E, Yu L, Jia L, Zhang B, Feng G, Liu R. MicroRNAs Promote the Progression of Sepsis-Induced Cardiomyopathy and Neurovascular Dysfunction Through Upregulation of NF-kappaB Signaling Pathway-Associated HDAC7/ACTN4. Front Neurol 2022;13:909828. [PMID: 35756932 DOI: 10.3389/fneur.2022.909828] [Reference Citation Analysis]
7 Sun T, Duan L, Li J, Guo H, Xiong M. Gypenoside XVII protects against spinal cord injury in mice by regulating the microRNA‑21‑mediated PTEN/AKT/mTOR pathway. Int J Mol Med 2021;48:146. [PMID: 34132355 DOI: 10.3892/ijmm.2021.4979] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
8 Wu H, Zhou X, Wang X, Cheng W, Hu X, Wang Y, Luo B, Huang W, Gu J. miR-34a in extracellular vesicles from bone marrow mesenchymal stem cells reduces rheumatoid arthritis inflammation via the cyclin I/ATM/ATR/p53 axis. J Cell Mol Med 2021;25:1896-910. [PMID: 33465281 DOI: 10.1111/jcmm.15857] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 9.0] [Reference Citation Analysis]
9 Fei M, Li Z, Cao Y, Jiang C, Lin H, Chen Z. MicroRNA-182 improves spinal cord injury in mice by modulating apoptosis and the inflammatory response via IKKβ/NF-κB. Lab Invest 2021;101:1238-53. [PMID: 34059758 DOI: 10.1038/s41374-021-00606-5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
10 Zhao N, Wang G, Long S, Hu M, Gao J, Ran X, Wang J, Su Y, Wang T. MicroRNA-34a deficiency leads to impaired wound closure by augmented inflammation in mice. Ann Transl Med 2020;8:447. [PMID: 32395491 DOI: 10.21037/atm.2020.03.161] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]